欢迎来到《四川大学学报(医学版)》

困难胰腺微创手术的临床实践与质量控制策略

Clinical Practice and Quality Control Strategies for Complex Minimally Invasive Pancreatic Surgery

  • 摘要: 随着微创理念的不断深入发展,胰腺外科正逐步迈向微创化的转型方向。相比传统开腹手术,微创手术具有创伤小、恢复快、并发症少等优势。然而,由于胰腺解剖结构复杂、手术操作难度大,其微创手术的推广依然面临诸多技术挑战。目前,腹腔镜胰十二指肠切除术主要在具备成熟团队和丰富经验的大型专科中心开展,其高难度和高风险特性使得“如何降低术中风险、减少术后并发症”仍为当前研究关注的重点与难点。本文将以困难胰腺微创手术术中风险控制与术后并发症管理为核心,全面回顾近年来国内外的研究进展,系统梳理在术前评估、术中操作、并发症防控、质量管理及技术创新等方面的最新成果。并进一步探讨胰腺微创外科在技术提升、学科建设、术式规范化及多中心协作等方向的发展潜力,旨在推动该领域向更规范化、个体化和智能化的方向持续迈进,最终惠及更多胰腺疾病患者。

     

    Abstract: With continuous advancements in the concepts of minimally invasive surgery, pancreatic surgery is gradually undergoing a transformative shift toward minimally invasive approaches. Compared with traditional open surgeries, minimally invasive procedures offer advantages such as reduced trauma, faster recovery, and fewer complications. However, due to the complex anatomical structure of the pancreas and the technical difficulties of surgical procedures, the widespread adoption of minimally invasive pancreatic surgery still faces numerous technical challenges. Currently, laparoscopic pancreaticoduodenectomy (LPD) is primarily performed in large, specialized centers with experienced teams and well-established systems. Given the high technical complexity and associated risks, reducing intraoperative risks and minimizing postoperative complications remain key focuses and major challenges in current research. This review is focused on intraoperative risk control and postoperative complication management in complex minimally invasive pancreatic surgery. We conducted a comprehensive review of recent advances in China and abroad, covering the latest progress in preoperative assessment, intraoperative procedures, complication prevention, quality management, and technological innovation. Furthermore, we discussed potential development directions in minimally invasive pancreatic surgery, including technical refinement, discipline development, procedural standardization, and multi-center collaboration. Our goal is to promote a continued progress toward more standardized, personalized, and intelligent surgical practices—ultimately benefiting a broader population of patients with pancreatic diseases.

     

/

返回文章
返回